CQS Cayman’s iShares Biotechnology ETF IBB Stock Holding History

CQS Cayman’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-2,550	Closed	-$246K	–	128
2016 Q3	$246K	Sell	2,550 -33,450	-93%	-$3.18M	0.02%	135
2016 Q2	$3.09M	Buy	+36,000	New	+$3.23M	0.27%	71
2015 Q4	–	Sell	-30,000	Closed	-$3.03M	–	155
2015 Q3	$3.03M	Buy	+30,000	New	+$3.6M	0.25%	74
2015 Q2	–	Sell	-18,150	Closed	-$2.08M	–	195
2015 Q1	$2.08M	Buy	18,150 +13,050	+256%	+$1.44M	0.1%	128
2014 Q4	$516K	Sell	5,100 -300	-6%	-$29.2K	0.03%	142
2014 Q3	$493K	Buy	+5,400	New	+$474K	0.03%	140

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

CQS Cayman's IBB Position: Q4 2016 in Review

CQS Cayman sold out of iShares Biotechnology ETF (IBB) in Q4 2016, closing a stake of 2,550 shares — an estimated $246K sold.

CQS Cayman first reported a position in IBB in Q3 2014 and held it in 6 quarters. The position peaked at $3.09M in Q2 2016. 523 funds tracked by Wall St. Rank hold IBB as of Q4 2016.

CQS Cayman reported no remaining iShares Biotechnology ETF position as of Q4 2016 after selling out during the quarter.
CQS Cayman sold 2,550 iShares Biotechnology ETF shares in Q4 2016, an estimated $246K.
CQS Cayman first reported a position in iShares Biotechnology ETF in Q3 2014 and held it in 6 quarters.
CQS Cayman's iShares Biotechnology ETF position peaked at $3.09M in Q2 2016.
523 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2016.

Based on CQS Cayman's 13F filing for Q4 2016, filed 14 Feb 2017.